2017 Fiscal Year Final Research Report
A novel mechanism for evasion of CTL immunity by altered O-glycosylation
Project/Area Number |
15K06989
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Functional biochemistry
|
Research Institution | Hirosaki University |
Principal Investigator |
TSUBOI Shigeru 弘前大学, 医学研究科, 客員研究員 (20526727)
|
Co-Investigator(Kenkyū-buntansha) |
大山 力 弘前大学, 医学研究科, 教授 (80282135)
|
Co-Investigator(Renkei-kenkyūsha) |
KAKIZAKI Ikuko 弘前大学, 大学院医学研究科, 准教授 (80302024)
|
Project Period (FY) |
2015-10-21 – 2018-03-31
|
Keywords | 腫瘍免疫 / 細胞傷害性Tリンパ球 / 膀胱癌 / 転移 |
Outline of Final Research Achievements |
We have tumor immunity to suppress cancer cell proliferation and metastasis.However, cancer exerts the versatile immune evasion strategies to predominate over tumor immunity. A series of our studies revealed that bladder cancer cells evade each tumor immune system by different evasion strategies using altered glycosylation. A glycosyltransferase, C2GnT forms a branched structure called core 2 O-glycans on cell-surface glycoproteins. To elucidate the roles of core 2 O-glycans in bladder cancer metastasis, we analyzed C2GnT expression in lymph node, a target organ. We showed that bladder cancer cells evade tumor immune system by cytotoxic T lymphocyte (CTL) by downregulating C2GnT expression. C2GnT-negative cancer cells evade CTL attack, resulting in indefinite proliferation in lymph node.
|
Free Research Field |
細胞生物学
|